Aromatherapy Effect on Pain and Anxiety After C-section

April 24, 2024 updated by: Nesrine Souayeh, University Tunis El Manar

Effect of Aromatherapy Using Lavender Essential Oil on Pain and Anxiety After C-section: a Randomized Controlled Trial

A prospective randomized triple blinded study conducted in the obstetrics gynecology department of Ben Arous hospital over a period of four months and 10 days between April 2023 and August 2023.

The aim of this study was to evaluate the effectiveness of lavender aromatherapy on postoperative pain and anxiety after cesarean section under spinal anesthesia in Tunisian women.

Study Overview

Status

Completed

Study Type

Interventional

Enrollment (Actual)

100

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Ben Arous, Tunisia
        • Ben Arous Regional Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • All women who gave birth by cesarean section under spinal anesthesia in the obstetrics and gynecology department at the Ben Arous regional hospital who met the following criteria were included in this study:

    • Age between 18 and 45 years old
    • Term of pregnancy at the time of delivery ≥ 37 weeks of Gestation.
    • A minimum level of primary education as a prerequisite to answer the questions (in particular the STAI items).
    • Classified ASA 1 or 2 of the American Society of Anesthesiology (ASA) classification.
    • Having no history of cancer or chronic pain.
    • Free from any psychiatric pathology.
    • And having not presented any intra- or post-operative complications.

Exclusion Criteria:

The investigators excluded patients in our study:

  • Having given birth to a stillborn or a suffering newborn requiring transfer to neonatal intensive care.
  • Having received painkillers in the post-operative period.
  • Having olfactory disorders.
  • Having a substance abuse problem.
  • Having a known allergy to lavender or other aromatic plants.
  • who did not agree to participate in the study or who did not continue all stages of the trial.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Quadruple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Aromatherapy group
Two to twelve hours after undergoing C-section, the women enrolled in the experimental arm benefited from aromatherapy with lavender essential oil (EO): The patients were invited to inhale cotton balls, soaked separately with three drops of the EO at a distance of 10 centimeters for 30 minutes.
women enrolled in the experimental group received aromatherapy with lavender essential oil (EO) through dry inhalation (inhalation via a cotton support soaked in a few drops of EO)
Placebo Comparator: Placebo
Two to twelve hours after undergoing C-section, the women enrolled in the placebo arm were invited to inhale cotton balls, soaked separately with three drops of the distilled water at a distance of 10 centimeters for 30 minutes.
women enrolled in the placebo group received ihaled a cotton support soaked in a few drops of distilled water

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Post-operative pain level
Time Frame: two to twelve hours after surgery
the investigator evaluated the Post-operative pain level using Visual analogue scale( patient at rest and after ambulation). The score ranges from 0 (no pain at all) to 10 (the worst imaginable pain). the higher the score is, the worst the outcome is.
two to twelve hours after surgery
Post-operative anxiety level
Time Frame: two to twelve hours after surgery
the investigator evaluated the Post-operative anxiety level using the " State Trait Anxiety Inventory (STAI)forme Y ". The score ranges from 20 to 80. Higher scores are associated with higher levels of anxiety (worse outcome)
two to twelve hours after surgery

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Heart Rate (HR)
Time Frame: two to twelve hours after surgery
Heart Rate in beat per minute (bpm),
two to twelve hours after surgery
Systolic Blood Pressure (SBP)
Time Frame: two to twelve hours after surgery
Systolic Blood Pressure (SBP) in millimetres of mercury (mmHg)
two to twelve hours after surgery
Diastolic Blood Pressure (DBP)
Time Frame: two to twelve hours after surgery
Diastolic Blood Pressure (DBP) in millimetres of mercury (mmHg)
two to twelve hours after surgery
Respiratory Rate (RR)
Time Frame: two to twelve hours after surgery
Respiratory Rate (RR) in cycle per minute (cpm)
two to twelve hours after surgery
Pulsatile Oxygen Saturation
Time Frame: two to twelve hours after surgery
Pulsatile Oxygen Saturation (SPO2) in percentage (%).
two to twelve hours after surgery

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Hajer Bettaieb, Professor, University of Tunis el Manar, Faculty of medicine

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 21, 2023

Primary Completion (Actual)

August 31, 2023

Study Completion (Actual)

August 31, 2023

Study Registration Dates

First Submitted

April 20, 2024

First Submitted That Met QC Criteria

April 24, 2024

First Posted (Actual)

April 29, 2024

Study Record Updates

Last Update Posted (Actual)

April 29, 2024

Last Update Submitted That Met QC Criteria

April 24, 2024

Last Verified

April 1, 2024

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Post-operative Pain

Clinical Trials on Aromatherapy

3
Subscribe